Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Diagnos Inc. (V:ADK)

Business Focus: Software

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for ADK within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Sep 28, 2020 13:11 ET
DIAGNOS Welcomes Mr. Vincent Duhamel and Mr. Robert J. Dunn to its Board of Directors
Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the...
Read full article
Sep 15, 2020 10:00 ET
DIAGNOS Announces a Multi-Year Contract with Chaparral Medical Group in California
Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK, OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today the signing of a three-year agreement with its US...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.93
--
--
Price to Sales - TTM
58.73
10.04
10.71
Price to Book - most recent quarter
12.97
5.35
4.92
Price to Cash Flow per share - TTM
--
16.72
16.83
Price to Free Cash Flow per share - TTM
--
46.34
24.88
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 202021,350-52,650
Aug 31, 202074,00067,634
Aug 15, 20206,366-4,134
See Short Report

Business Summary

Sector:  Technology Industry:  Software

DIAGNOS Inc. provides data mining and interpretation consulting services, and designs data analytics software products. The Company operates through two segments: Healthcare and Natural resources. Its Healthcare segment offers image analysis services through Computer Assisted Retinal Analysis (CARA), a software tool, which assists health specialists in the detection of diabetic retinopathy. CARA is a hosted Web-based application that integrates fundus cameras with an image processing engine over an Internet connection. Its Natural resources segment offers data mining consulting services through Computer Aided Resource Detection System (CARDS), a software tool used to assist exploration companies in identifying mining deposits. In addition, it offers project management services. The Company operates in Canada, the United Arab Emirates, India, Mexico, Switzerland, the United States, Poland and Colombia.

See business summary

 

Twitter

Search (past week) for $ADK.CA ADK.V

  • No tweets found